{"transactions":[{"id":1443070,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-02T18:00:22.000Z","date":"2024-08-01","kind":"exercise","planned":false,"acquired":false,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1507},"source":{"system":"sec-edgar","filing":"0001415889-24-020662","document":"form4-08022024_060818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924020662/form4-08022024_060818.xml","form_type":"4"}},{"id":1443069,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-02T18:00:22.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":false,"shares":10548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":1507,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":10548},"source":{"system":"sec-edgar","filing":"0001415889-24-020662","document":"form4-08022024_060818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924020662/form4-08022024_060818.xml","form_type":"4"}},{"id":1443068,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-02T18:00:22.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":false,"shares":906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":906},"source":{"system":"sec-edgar","filing":"0001415889-24-020662","document":"form4-08022024_060818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924020662/form4-08022024_060818.xml","form_type":"4"}},{"id":1443067,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-08-02T18:00:22.000Z","date":"2024-08-01","kind":"exercise","planned":false,"acquired":true,"shares":1507,"price":1.74,"value":2622.18,"ownership":{"direct":true},"balance_after":14252,"source":{"system":"sec-edgar","filing":"0001415889-24-020662","document":"form4-08022024_060818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924020662/form4-08022024_060818.xml","form_type":"4"}},{"id":1443066,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-08-02T18:00:22.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":true,"shares":11454,"price":1.74,"value":19929.96,"ownership":{"direct":true},"balance_after":12745,"source":{"system":"sec-edgar","filing":"0001415889-24-020662","document":"form4-08022024_060818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924020662/form4-08022024_060818.xml","form_type":"4"}},{"id":1538508,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-19T18:00:16.000Z","date":"2024-04-17","kind":"exercise","planned":true,"acquired":false,"shares":6853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":95936,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":6853},"source":{"system":"sec-edgar","filing":"0001415889-24-011252","document":"form4-04192024_060407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924011252/form4-04192024_060407.xml","form_type":"4"}},{"id":1538507,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-04-19T18:00:16.000Z","date":"2024-04-17","kind":"sale","planned":true,"acquired":false,"shares":68,"price":23.97,"value":1629.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-24-011252","document":"form4-04192024_060407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924011252/form4-04192024_060407.xml","form_type":"4"}},{"id":1538506,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-04-19T18:00:16.000Z","date":"2024-04-17","kind":"sale","planned":true,"acquired":false,"shares":338,"price":23.1699,"value":7831.4262,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.825 to $23.65, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1359,"source":{"system":"sec-edgar","filing":"0001415889-24-011252","document":"form4-04192024_060407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924011252/form4-04192024_060407.xml","form_type":"4"}},{"id":1538505,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-04-19T18:00:16.000Z","date":"2024-04-17","kind":"sale","planned":true,"acquired":false,"shares":6447,"price":22.3151,"value":143865.4497,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.812 to $22.80, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1697,"source":{"system":"sec-edgar","filing":"0001415889-24-011252","document":"form4-04192024_060407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924011252/form4-04192024_060407.xml","form_type":"4"}},{"id":1538504,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-04-19T18:00:16.000Z","date":"2024-04-17","kind":"exercise","planned":true,"acquired":true,"shares":6853,"price":2.14,"value":14665.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."}],"balance_after":8144,"source":{"system":"sec-edgar","filing":"0001415889-24-011252","document":"form4-04192024_060407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924011252/form4-04192024_060407.xml","form_type":"4"}},{"id":1550244,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-03T18:00:18.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":false,"shares":3325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 58,000 shares subject to an employee stock option were granted on December 14, 2021, with the first installment vested on January 14, 2022, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":25675,"derivative":{"exercise_price":10.61,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":3325},"source":{"system":"sec-edgar","filing":"0001415889-24-010137","document":"form4-04032024_060406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924010137/form4-04032024_060406.xml","form_type":"4"}},{"id":1550243,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-04-03T18:00:18.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":3325,"price":31.9749,"value":106316.5425,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.95 to $32.415, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-24-010137","document":"form4-04032024_060406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924010137/form4-04032024_060406.xml","form_type":"4"}},{"id":1550242,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-04-03T18:00:18.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":true,"shares":3325,"price":10.61,"value":35278.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."}],"balance_after":4616,"source":{"system":"sec-edgar","filing":"0001415889-24-010137","document":"form4-04032024_060406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924010137/form4-04032024_060406.xml","form_type":"4"}},{"id":1558588,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-28T18:00:13.000Z","date":"2024-03-27","kind":"exercise","planned":true,"acquired":false,"shares":11068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 58,000 shares subject to an employee stock option were granted on December 14, 2021, with the first installment vested on January 14, 2022, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":29000,"derivative":{"exercise_price":10.61,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":11068},"source":{"system":"sec-edgar","filing":"0001415889-24-009364","document":"form4-03282024_060301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924009364/form4-03282024_060301.xml","form_type":"4"}},{"id":1558587,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-28T18:00:13.000Z","date":"2024-03-27","kind":"sale","planned":true,"acquired":false,"shares":11068,"price":27.9652,"value":309518.8336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.95 to $28.18, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-24-009364","document":"form4-03282024_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924009364/form4-03282024_060301.xml","form_type":"4"}},{"id":1558586,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-28T18:00:13.000Z","date":"2024-03-27","kind":"exercise","planned":true,"acquired":true,"shares":11068,"price":10.61,"value":117431.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."}],"balance_after":12359,"source":{"system":"sec-edgar","filing":"0001415889-24-009364","document":"form4-03282024_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924009364/form4-03282024_060301.xml","form_type":"4"}},{"id":1559678,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-27T18:00:12.000Z","date":"2024-03-25","kind":"exercise","planned":true,"acquired":false,"shares":3432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 58,000 shares subject to an employee stock option were granted on December 14, 2021, with the first installment vested on January 14, 2022, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":40068,"derivative":{"exercise_price":10.61,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":3432},"source":{"system":"sec-edgar","filing":"0001415889-24-009243","document":"form4-03272024_060301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924009243/form4-03272024_060301.xml","form_type":"4"}},{"id":1559677,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-27T18:00:12.000Z","date":"2024-03-25","kind":"sale","planned":true,"acquired":false,"shares":3432,"price":28.0068,"value":96119.3376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.95 to $28.385, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-24-009243","document":"form4-03272024_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924009243/form4-03272024_060301.xml","form_type":"4"}},{"id":1559676,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-27T18:00:12.000Z","date":"2024-03-25","kind":"exercise","planned":true,"acquired":true,"shares":3432,"price":10.61,"value":36413.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."}],"balance_after":4723,"source":{"system":"sec-edgar","filing":"0001415889-24-009243","document":"form4-03272024_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924009243/form4-03272024_060301.xml","form_type":"4"}},{"id":1566177,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-20T18:00:17.000Z","date":"2024-03-18","kind":"exercise","planned":true,"acquired":false,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 58,000 shares subject to an employee stock option were granted on December 14, 2021, with the first installment vested on January 14, 2022, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":43500,"derivative":{"exercise_price":10.61,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001415889-24-008770","document":"form4-03202024_060307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924008770/form4-03202024_060307.xml","form_type":"4"}},{"id":1566176,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-20T18:00:17.000Z","date":"2024-03-18","kind":"exercise","planned":true,"acquired":false,"shares":20557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":102789,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":20557},"source":{"system":"sec-edgar","filing":"0001415889-24-008770","document":"form4-03202024_060307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924008770/form4-03202024_060307.xml","form_type":"4"}},{"id":1566175,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-20T18:00:17.000Z","date":"2024-03-18","kind":"sale","planned":true,"acquired":false,"shares":7581,"price":26.4825,"value":200763.8325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.25 to $26.88, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-24-008770","document":"form4-03202024_060307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924008770/form4-03202024_060307.xml","form_type":"4"}},{"id":1566174,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-20T18:00:17.000Z","date":"2024-03-18","kind":"sale","planned":true,"acquired":false,"shares":27476,"price":25.7418,"value":707281.6968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.235 to $26.234, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":8872,"source":{"system":"sec-edgar","filing":"0001415889-24-008770","document":"form4-03202024_060307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924008770/form4-03202024_060307.xml","form_type":"4"}},{"id":1566173,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-20T18:00:17.000Z","date":"2024-03-18","kind":"exercise","planned":true,"acquired":true,"shares":14500,"price":10.61,"value":153845.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."}],"balance_after":36348,"source":{"system":"sec-edgar","filing":"0001415889-24-008770","document":"form4-03202024_060307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924008770/form4-03202024_060307.xml","form_type":"4"}},{"id":1566172,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-20T18:00:17.000Z","date":"2024-03-18","kind":"exercise","planned":true,"acquired":true,"shares":20557,"price":2.14,"value":43991.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023."}],"balance_after":21848,"source":{"system":"sec-edgar","filing":"0001415889-24-008770","document":"form4-03202024_060307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924008770/form4-03202024_060307.xml","form_type":"4"}},{"id":1672206,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-01-24T18:00:16.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":66586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on February 22, 2024."}],"balance_after":66586,"derivative":{"exercise_price":20,"expiration_date":"2034-01-21","underlying":"Common Stock","underlying_shares":66586},"source":{"system":"sec-edgar","filing":"0001415889-24-001773","document":"form4-01242024_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588924001773/form4-01242024_060101.xml","form_type":"4"}},{"id":1719187,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-07T18:00:10.000Z","date":"2023-12-06","kind":"exercise","planned":true,"acquired":false,"shares":6853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":123346,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":6853},"source":{"system":"sec-edgar","filing":"0001415889-23-015986","document":"form4-12072023_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015986/form4-12072023_061201.xml","form_type":"4"}},{"id":1719186,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-07T18:00:10.000Z","date":"2023-12-06","kind":"exercise","planned":true,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":16294,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001415889-23-015986","document":"form4-12072023_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015986/form4-12072023_061201.xml","form_type":"4"}},{"id":1719185,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-07T18:00:10.000Z","date":"2023-12-06","kind":"exercise","planned":true,"acquired":false,"shares":1506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":12055,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1506},"source":{"system":"sec-edgar","filing":"0001415889-23-015986","document":"form4-12072023_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015986/form4-12072023_061201.xml","form_type":"4"}},{"id":1719184,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-07T18:00:10.000Z","date":"2023-12-06","kind":"exercise","planned":true,"acquired":false,"shares":905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":906,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":905},"source":{"system":"sec-edgar","filing":"0001415889-23-015986","document":"form4-12072023_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015986/form4-12072023_061201.xml","form_type":"4"}},{"id":1719183,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-12-07T18:00:10.000Z","date":"2023-12-06","kind":"sale","planned":true,"acquired":false,"shares":10283,"price":16.107,"value":165628.281,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.71 to $16.455, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-23-015986","document":"form4-12072023_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015986/form4-12072023_061201.xml","form_type":"4"}},{"id":1719182,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-12-07T18:00:10.000Z","date":"2023-12-06","kind":"exercise","planned":true,"acquired":true,"shares":7872,"price":2.14,"value":16846.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":11574,"source":{"system":"sec-edgar","filing":"0001415889-23-015986","document":"form4-12072023_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015986/form4-12072023_061201.xml","form_type":"4"}},{"id":1719181,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-12-07T18:00:10.000Z","date":"2023-12-06","kind":"exercise","planned":true,"acquired":true,"shares":2411,"price":1.74,"value":4195.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":3702,"source":{"system":"sec-edgar","filing":"0001415889-23-015986","document":"form4-12072023_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015986/form4-12072023_061201.xml","form_type":"4"}},{"id":1727820,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-29T18:00:09.000Z","date":"2023-11-27","kind":"exercise","planned":true,"acquired":false,"shares":9086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":130199,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":9086},"source":{"system":"sec-edgar","filing":"0001415889-23-015599","document":"form4-11292023_061101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015599/form4-11292023_061101.xml","form_type":"4"}},{"id":1727819,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-29T18:00:09.000Z","date":"2023-11-27","kind":"exercise","planned":true,"acquired":false,"shares":1018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":17313,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1018},"source":{"system":"sec-edgar","filing":"0001415889-23-015599","document":"form4-11292023_061101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015599/form4-11292023_061101.xml","form_type":"4"}},{"id":1727818,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-29T18:00:09.000Z","date":"2023-11-27","kind":"exercise","planned":true,"acquired":false,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":13561,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1507},"source":{"system":"sec-edgar","filing":"0001415889-23-015599","document":"form4-11292023_061101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015599/form4-11292023_061101.xml","form_type":"4"}},{"id":1727817,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-29T18:00:09.000Z","date":"2023-11-27","kind":"exercise","planned":true,"acquired":false,"shares":906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":1811,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":906},"source":{"system":"sec-edgar","filing":"0001415889-23-015599","document":"form4-11292023_061101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015599/form4-11292023_061101.xml","form_type":"4"}},{"id":1727816,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-11-29T18:00:09.000Z","date":"2023-11-27","kind":"sale","planned":true,"acquired":false,"shares":12517,"price":16.2369,"value":203237.2773,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.635 to $16.58, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-23-015599","document":"form4-11292023_061101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015599/form4-11292023_061101.xml","form_type":"4"}},{"id":1727815,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-11-29T18:00:09.000Z","date":"2023-11-27","kind":"exercise","planned":true,"acquired":true,"shares":10104,"price":2.14,"value":21622.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":13808,"source":{"system":"sec-edgar","filing":"0001415889-23-015599","document":"form4-11292023_061101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015599/form4-11292023_061101.xml","form_type":"4"}},{"id":1727814,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-11-29T18:00:09.000Z","date":"2023-11-27","kind":"exercise","planned":true,"acquired":true,"shares":2413,"price":1.74,"value":4198.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":3704,"source":{"system":"sec-edgar","filing":"0001415889-23-015599","document":"form4-11292023_061101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015599/form4-11292023_061101.xml","form_type":"4"}},{"id":1729644,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-27T18:00:50.000Z","date":"2023-11-24","kind":"exercise","planned":true,"acquired":false,"shares":4619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":139285,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":4619},"source":{"system":"sec-edgar","filing":"0001415889-23-015509","document":"form4-11272023_061104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015509/form4-11272023_061104.xml","form_type":"4"}},{"id":1729643,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-27T18:00:50.000Z","date":"2023-11-24","kind":"exercise","planned":true,"acquired":false,"shares":371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":18331,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":371},"source":{"system":"sec-edgar","filing":"0001415889-23-015509","document":"form4-11272023_061104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015509/form4-11272023_061104.xml","form_type":"4"}},{"id":1729642,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-27T18:00:50.000Z","date":"2023-11-22","kind":"exercise","planned":true,"acquired":false,"shares":6322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":143904,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":6322},"source":{"system":"sec-edgar","filing":"0001415889-23-015509","document":"form4-11272023_061104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015509/form4-11272023_061104.xml","form_type":"4"}},{"id":1729641,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-27T18:00:50.000Z","date":"2023-11-22","kind":"exercise","planned":true,"acquired":false,"shares":648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":18702,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":648},"source":{"system":"sec-edgar","filing":"0001415889-23-015509","document":"form4-11272023_061104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015509/form4-11272023_061104.xml","form_type":"4"}},{"id":1729640,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-27T18:00:50.000Z","date":"2023-11-22","kind":"exercise","planned":true,"acquired":false,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":15068,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1507},"source":{"system":"sec-edgar","filing":"0001415889-23-015509","document":"form4-11272023_061104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015509/form4-11272023_061104.xml","form_type":"4"}},{"id":1729639,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-27T18:00:50.000Z","date":"2023-11-22","kind":"exercise","planned":true,"acquired":false,"shares":905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":2717,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":905},"source":{"system":"sec-edgar","filing":"0001415889-23-015509","document":"form4-11272023_061104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015509/form4-11272023_061104.xml","form_type":"4"}},{"id":1729638,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-11-27T18:00:50.000Z","date":"2023-11-24","kind":"sale","planned":true,"acquired":false,"shares":70,"price":16.0656,"value":1124.592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.035 to $16.11, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-23-015509","document":"form4-11272023_061104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015509/form4-11272023_061104.xml","form_type":"4"}},{"id":1729637,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-11-27T18:00:50.000Z","date":"2023-11-24","kind":"sale","planned":true,"acquired":false,"shares":4920,"price":15.7364,"value":77423.088,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.034 to $16.025, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1361,"source":{"system":"sec-edgar","filing":"0001415889-23-015509","document":"form4-11272023_061104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015509/form4-11272023_061104.xml","form_type":"4"}},{"id":1729636,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-11-27T18:00:50.000Z","date":"2023-11-24","kind":"exercise","planned":true,"acquired":true,"shares":4990,"price":2.14,"value":10678.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":6281,"source":{"system":"sec-edgar","filing":"0001415889-23-015509","document":"form4-11272023_061104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015509/form4-11272023_061104.xml","form_type":"4"}},{"id":1729635,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-11-27T18:00:50.000Z","date":"2023-11-22","kind":"sale","planned":true,"acquired":false,"shares":9382,"price":15.1736,"value":142358.7152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.37, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-23-015509","document":"form4-11272023_061104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015509/form4-11272023_061104.xml","form_type":"4"}},{"id":1729634,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-11-27T18:00:50.000Z","date":"2023-11-22","kind":"exercise","planned":true,"acquired":true,"shares":6970,"price":2.14,"value":14915.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":10673,"source":{"system":"sec-edgar","filing":"0001415889-23-015509","document":"form4-11272023_061104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015509/form4-11272023_061104.xml","form_type":"4"}},{"id":1729633,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-11-27T18:00:50.000Z","date":"2023-11-22","kind":"exercise","planned":true,"acquired":true,"shares":2412,"price":1.74,"value":4196.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":3703,"source":{"system":"sec-edgar","filing":"0001415889-23-015509","document":"form4-11272023_061104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923015509/form4-11272023_061104.xml","form_type":"4"}},{"id":1784837,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-08T18:00:08.000Z","date":"2023-09-07","kind":"exercise","planned":true,"acquired":false,"shares":30,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":150226,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":30},"source":{"system":"sec-edgar","filing":"0001415889-23-013130","document":"form4-09082023_060901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923013130/form4-09082023_060901.xml","form_type":"4"}},{"id":1784836,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-08T18:00:08.000Z","date":"2023-09-06","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":150256,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001415889-23-013130","document":"form4-09082023_060901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923013130/form4-09082023_060901.xml","form_type":"4"}},{"id":1784835,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-08T18:00:08.000Z","date":"2023-09-06","kind":"exercise","planned":true,"acquired":false,"shares":1018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":19350,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1018},"source":{"system":"sec-edgar","filing":"0001415889-23-013130","document":"form4-09082023_060901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923013130/form4-09082023_060901.xml","form_type":"4"}},{"id":1784834,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-08T18:00:08.000Z","date":"2023-09-06","kind":"exercise","planned":true,"acquired":false,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":16575,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1507},"source":{"system":"sec-edgar","filing":"0001415889-23-013130","document":"form4-09082023_060901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923013130/form4-09082023_060901.xml","form_type":"4"}},{"id":1784833,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-08T18:00:08.000Z","date":"2023-09-06","kind":"exercise","planned":true,"acquired":false,"shares":906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":3622,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":906},"source":{"system":"sec-edgar","filing":"0001415889-23-013130","document":"form4-09082023_060901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923013130/form4-09082023_060901.xml","form_type":"4"}},{"id":1784832,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-09-08T18:00:08.000Z","date":"2023-09-07","kind":"sale","planned":true,"acquired":false,"shares":30,"price":15.01,"value":450.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-23-013130","document":"form4-09082023_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923013130/form4-09082023_060901.xml","form_type":"4"}},{"id":1784831,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-09-08T18:00:08.000Z","date":"2023-09-07","kind":"exercise","planned":true,"acquired":true,"shares":30,"price":2.14,"value":64.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":1321,"source":{"system":"sec-edgar","filing":"0001415889-23-013130","document":"form4-09082023_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923013130/form4-09082023_060901.xml","form_type":"4"}},{"id":1784830,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-09-08T18:00:08.000Z","date":"2023-09-06","kind":"sale","planned":true,"acquired":false,"shares":3931,"price":15.0564,"value":59186.7084,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.29, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-23-013130","document":"form4-09082023_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923013130/form4-09082023_060901.xml","form_type":"4"}},{"id":1784829,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-09-08T18:00:08.000Z","date":"2023-09-06","kind":"exercise","planned":true,"acquired":true,"shares":1518,"price":2.14,"value":3248.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":5222,"source":{"system":"sec-edgar","filing":"0001415889-23-013130","document":"form4-09082023_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923013130/form4-09082023_060901.xml","form_type":"4"}},{"id":1784828,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-09-08T18:00:08.000Z","date":"2023-09-06","kind":"exercise","planned":true,"acquired":true,"shares":2413,"price":1.74,"value":4198.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":3704,"source":{"system":"sec-edgar","filing":"0001415889-23-013130","document":"form4-09082023_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923013130/form4-09082023_060901.xml","form_type":"4"}},{"id":1812167,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-09T18:00:15.000Z","date":"2023-08-07","kind":"exercise","planned":true,"acquired":false,"shares":6853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":150756,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":6853},"source":{"system":"sec-edgar","filing":"0001415889-23-011986","document":"form4-08092023_060801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923011986/form4-08092023_060801.xml","form_type":"4"}},{"id":1812166,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-09T18:00:15.000Z","date":"2023-08-07","kind":"exercise","planned":true,"acquired":false,"shares":1018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":20368,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1018},"source":{"system":"sec-edgar","filing":"0001415889-23-011986","document":"form4-08092023_060801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923011986/form4-08092023_060801.xml","form_type":"4"}},{"id":1812165,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-09T18:00:15.000Z","date":"2023-08-07","kind":"exercise","planned":true,"acquired":false,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":18082,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1507},"source":{"system":"sec-edgar","filing":"0001415889-23-011986","document":"form4-08092023_060801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923011986/form4-08092023_060801.xml","form_type":"4"}},{"id":1812164,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-09T18:00:15.000Z","date":"2023-08-07","kind":"exercise","planned":true,"acquired":false,"shares":905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the\nshares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":4528,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":905},"source":{"system":"sec-edgar","filing":"0001415889-23-011986","document":"form4-08092023_060801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923011986/form4-08092023_060801.xml","form_type":"4"}},{"id":1812163,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-08-09T18:00:15.000Z","date":"2023-08-07","kind":"sale","planned":true,"acquired":false,"shares":541,"price":16.2451,"value":8788.5991,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.175 to $16.470, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-23-011986","document":"form4-08092023_060801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923011986/form4-08092023_060801.xml","form_type":"4"}},{"id":1812162,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-08-09T18:00:15.000Z","date":"2023-08-07","kind":"sale","planned":true,"acquired":false,"shares":9742,"price":15.4785,"value":150791.547,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.17 to $16.17, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1832,"source":{"system":"sec-edgar","filing":"0001415889-23-011986","document":"form4-08092023_060801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923011986/form4-08092023_060801.xml","form_type":"4"}},{"id":1812161,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-08-09T18:00:15.000Z","date":"2023-08-07","kind":"exercise","planned":true,"acquired":true,"shares":7871,"price":2.14,"value":16843.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":11574,"source":{"system":"sec-edgar","filing":"0001415889-23-011986","document":"form4-08092023_060801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923011986/form4-08092023_060801.xml","form_type":"4"}},{"id":1812160,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-08-09T18:00:15.000Z","date":"2023-08-07","kind":"exercise","planned":true,"acquired":true,"shares":2412,"price":1.74,"value":4196.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":3703,"source":{"system":"sec-edgar","filing":"0001415889-23-011986","document":"form4-08092023_060801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923011986/form4-08092023_060801.xml","form_type":"4"}},{"id":1833049,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-07T18:00:16.000Z","date":"2023-07-06","kind":"exercise","planned":true,"acquired":false,"shares":6852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":157609,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":6852},"source":{"system":"sec-edgar","filing":"0001415889-23-010966","document":"form4-07072023_060704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923010966/form4-07072023_060704.xml","form_type":"4"}},{"id":1833048,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-07T18:00:16.000Z","date":"2023-07-06","kind":"exercise","planned":true,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":21386,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001415889-23-010966","document":"form4-07072023_060704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923010966/form4-07072023_060704.xml","form_type":"4"}},{"id":1833047,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-07T18:00:16.000Z","date":"2023-07-06","kind":"exercise","planned":true,"acquired":false,"shares":1506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":19589,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1506},"source":{"system":"sec-edgar","filing":"0001415889-23-010966","document":"form4-07072023_060704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923010966/form4-07072023_060704.xml","form_type":"4"}},{"id":1833046,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-07T18:00:16.000Z","date":"2023-07-06","kind":"exercise","planned":true,"acquired":false,"shares":906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the\nshares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":5433,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":906},"source":{"system":"sec-edgar","filing":"0001415889-23-010966","document":"form4-07072023_060704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923010966/form4-07072023_060704.xml","form_type":"4"}},{"id":1833045,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-07-07T18:00:16.000Z","date":"2023-07-06","kind":"sale","planned":true,"acquired":false,"shares":10283,"price":16.657,"value":171283.931,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.31 to $17.225, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-23-010966","document":"form4-07072023_060704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923010966/form4-07072023_060704.xml","form_type":"4"}},{"id":1833044,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-07-07T18:00:16.000Z","date":"2023-07-06","kind":"exercise","planned":true,"acquired":true,"shares":7871,"price":2.14,"value":16843.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":11574,"source":{"system":"sec-edgar","filing":"0001415889-23-010966","document":"form4-07072023_060704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923010966/form4-07072023_060704.xml","form_type":"4"}},{"id":1833043,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-07-07T18:00:16.000Z","date":"2023-07-06","kind":"exercise","planned":true,"acquired":true,"shares":2412,"price":1.74,"value":4196.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":3703,"source":{"system":"sec-edgar","filing":"0001415889-23-010966","document":"form4-07072023_060704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923010966/form4-07072023_060704.xml","form_type":"4"}},{"id":1862705,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T18:00:43.000Z","date":"2023-06-06","kind":"exercise","planned":true,"acquired":false,"shares":6853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":164461,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":6853},"source":{"system":"sec-edgar","filing":"0001415889-23-009448","document":"form4-06082023_060620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923009448/form4-06082023_060620.xml","form_type":"4"}},{"id":1862704,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T18:00:43.000Z","date":"2023-06-06","kind":"exercise","planned":true,"acquired":false,"shares":1018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":22405,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1018},"source":{"system":"sec-edgar","filing":"0001415889-23-009448","document":"form4-06082023_060620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923009448/form4-06082023_060620.xml","form_type":"4"}},{"id":1862703,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T18:00:43.000Z","date":"2023-06-06","kind":"exercise","planned":true,"acquired":false,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":21095,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1507},"source":{"system":"sec-edgar","filing":"0001415889-23-009448","document":"form4-06082023_060620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923009448/form4-06082023_060620.xml","form_type":"4"}},{"id":1862702,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T18:00:43.000Z","date":"2023-06-06","kind":"exercise","planned":true,"acquired":false,"shares":905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the\nshares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":6339,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":905},"source":{"system":"sec-edgar","filing":"0001415889-23-009448","document":"form4-06082023_060620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923009448/form4-06082023_060620.xml","form_type":"4"}},{"id":1862701,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-06-08T18:00:43.000Z","date":"2023-06-06","kind":"sale","planned":true,"acquired":false,"shares":15,"price":16.975,"value":254.625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-23-009448","document":"form4-06082023_060620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923009448/form4-06082023_060620.xml","form_type":"4"}},{"id":1862700,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-06-08T18:00:43.000Z","date":"2023-06-06","kind":"sale","planned":true,"acquired":false,"shares":10268,"price":16.2798,"value":167160.9864,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.84 to $16.82, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1306,"source":{"system":"sec-edgar","filing":"0001415889-23-009448","document":"form4-06082023_060620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923009448/form4-06082023_060620.xml","form_type":"4"}},{"id":1862699,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-06-08T18:00:43.000Z","date":"2023-06-06","kind":"exercise","planned":true,"acquired":true,"shares":7871,"price":2.14,"value":16843.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":11574,"source":{"system":"sec-edgar","filing":"0001415889-23-009448","document":"form4-06082023_060620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923009448/form4-06082023_060620.xml","form_type":"4"}},{"id":1862698,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-06-08T18:00:43.000Z","date":"2023-06-06","kind":"exercise","planned":true,"acquired":true,"shares":2412,"price":1.74,"value":4196.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":3703,"source":{"system":"sec-edgar","filing":"0001415889-23-009448","document":"form4-06082023_060620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923009448/form4-06082023_060620.xml","form_type":"4"}},{"id":1899692,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T18:00:19.000Z","date":"2023-05-08","kind":"exercise","planned":true,"acquired":false,"shares":6853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":171314,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":6853},"source":{"system":"sec-edgar","filing":"0001415889-23-007686","document":"form4-05092023_060505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923007686/form4-05092023_060505.xml","form_type":"4"}},{"id":1899691,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T18:00:19.000Z","date":"2023-05-08","kind":"exercise","planned":true,"acquired":false,"shares":1018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":23423,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1018},"source":{"system":"sec-edgar","filing":"0001415889-23-007686","document":"form4-05092023_060505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923007686/form4-05092023_060505.xml","form_type":"4"}},{"id":1899690,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T18:00:19.000Z","date":"2023-05-08","kind":"exercise","planned":true,"acquired":false,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":22602,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1507},"source":{"system":"sec-edgar","filing":"0001415889-23-007686","document":"form4-05092023_060505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923007686/form4-05092023_060505.xml","form_type":"4"}},{"id":1899689,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T18:00:19.000Z","date":"2023-05-08","kind":"exercise","planned":true,"acquired":false,"shares":906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the\nshares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":7244,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":906},"source":{"system":"sec-edgar","filing":"0001415889-23-007686","document":"form4-05092023_060505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923007686/form4-05092023_060505.xml","form_type":"4"}},{"id":1899688,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-05-09T18:00:19.000Z","date":"2023-05-08","kind":"sale","planned":true,"acquired":false,"shares":1599,"price":22.7358,"value":36354.5442,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.15 to $23.12, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1291,"source":{"system":"sec-edgar","filing":"0001415889-23-007686","document":"form4-05092023_060505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923007686/form4-05092023_060505.xml","form_type":"4"}},{"id":1899687,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-05-09T18:00:19.000Z","date":"2023-05-08","kind":"sale","planned":true,"acquired":false,"shares":8685,"price":21.6241,"value":187805.3085,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.12 to $22.10, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":2890,"source":{"system":"sec-edgar","filing":"0001415889-23-007686","document":"form4-05092023_060505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923007686/form4-05092023_060505.xml","form_type":"4"}},{"id":1899686,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-05-09T18:00:19.000Z","date":"2023-05-08","kind":"exercise","planned":true,"acquired":true,"shares":7871,"price":2.14,"value":16843.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":11575,"source":{"system":"sec-edgar","filing":"0001415889-23-007686","document":"form4-05092023_060505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923007686/form4-05092023_060505.xml","form_type":"4"}},{"id":1899685,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-05-09T18:00:19.000Z","date":"2023-05-08","kind":"exercise","planned":true,"acquired":true,"shares":2413,"price":1.74,"value":4198.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,291 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2023 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d)."}],"balance_after":3704,"source":{"system":"sec-edgar","filing":"0001415889-23-007686","document":"form4-05092023_060505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923007686/form4-05092023_060505.xml","form_type":"4"}},{"id":1923058,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-07T18:00:17.000Z","date":"2023-04-06","kind":"exercise","planned":false,"acquired":false,"shares":6852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments."}],"balance_after":178167,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":6852},"source":{"system":"sec-edgar","filing":"0001415889-23-006377","document":"form4-04072023_060403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923006377/form4-04072023_060403.xml","form_type":"4"}},{"id":1923057,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-07T18:00:17.000Z","date":"2023-04-06","kind":"exercise","planned":false,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 48,882 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on May 2, 2021, with shares vesting in 48 substantially equal monthly installments."}],"balance_after":24441,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001415889-23-006377","document":"form4-04072023_060403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923006377/form4-04072023_060403.xml","form_type":"4"}},{"id":1923056,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-07T18:00:17.000Z","date":"2023-04-06","kind":"exercise","planned":false,"acquired":false,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 72,325 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":24109,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1507},"source":{"system":"sec-edgar","filing":"0001415889-23-006377","document":"form4-04072023_060403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923006377/form4-04072023_060403.xml","form_type":"4"}},{"id":1923055,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-07T18:00:17.000Z","date":"2023-04-06","kind":"exercise","planned":false,"acquired":false,"shares":905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the\nshares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":8150,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":905},"source":{"system":"sec-edgar","filing":"0001415889-23-006377","document":"form4-04072023_060403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923006377/form4-04072023_060403.xml","form_type":"4"}},{"id":1923054,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-04-07T18:00:17.000Z","date":"2023-04-06","kind":"sale","planned":false,"acquired":false,"shares":10283,"price":18.1687,"value":186828.7421,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.785 to $18.58, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-006377","document":"form4-04072023_060403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923006377/form4-04072023_060403.xml","form_type":"4"}},{"id":1923053,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-04-07T18:00:17.000Z","date":"2023-04-06","kind":"exercise","planned":false,"acquired":true,"shares":7871,"price":2.14,"value":16843.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":10283,"source":{"system":"sec-edgar","filing":"0001415889-23-006377","document":"form4-04072023_060403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923006377/form4-04072023_060403.xml","form_type":"4"}},{"id":1923052,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":88536,"kind":"person","name":"Dake Benjamin T","position":1,"cik":"0001869248","reported_name":"Dake Benjamin T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-04-07T18:00:17.000Z","date":"2023-04-06","kind":"exercise","planned":false,"acquired":true,"shares":2412,"price":1.74,"value":4196.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022."}],"balance_after":2412,"source":{"system":"sec-edgar","filing":"0001415889-23-006377","document":"form4-04072023_060403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869248/000141588923006377/form4-04072023_060403.xml","form_type":"4"}}],"next_cursor":"2023-04-07T18:00:17.000000Z,1923052"}